Related Experiment Video
Updated: Nov 11, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Epigenetic regulation of papillary thyroid carcinoma by long non-coding RNAs
Rui-Xin Lin1, Shu-Li Yang2, Yan Jia2
1Department of Hepato-Biliary-Pancreatic Surgery, The Second Hospital of Jilin University, Changchun, 130041, China.
Abstract:
Thyroid cancer is the most common primary endocrine malignancy with papillary thyroid carcinoma (PTC) its most common subtype. The jump in diagnoses over last many years has prompted re-assessment of molecularly targeted therapies and the discovery of novel targets. Long non-coding RNAs (lncRNAs) are increasingly being assessed for their expression in various PTC models. Interestingly, in addition to cell line models, a large proportion of the reported studies have evaluated lncRNA levels in PTC patient samples providing an immediate clinical relevance of their findings. While most lncRNAs either promote or suppress PTC pathogenesis, data on individual lncRNAs is not very clear. As expected, lncRNAs function in PTC through sponging of microRNAs as well as modulation of several signaling pathways. The process of epithelial-mesenchymal transition and the PI3K/Akt and wnt signaling pathways have emerged as the primary targets of lncRNAs in PTC. This comprehensive review discusses all the information that is available on lncRNAs in PTC, ranging from in vitro and in vivo findings to the possible role of lncRNAs as diagnostic and/or prognostic biomarkers.
Insights
Long non-coding RNAs (lncRNAs) are key players in papillary thyroid carcinoma (PTC) development. This review explores their roles, potential as biomarkers, and therapeutic targets in PTC.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy, with rising diagnoses necessitating new therapeutic strategies.
- Long non-coding RNAs (lncRNAs) are emerging as critical regulators in PTC pathogenesis.
- Studies increasingly investigate lncRNA expression in both cell models and patient samples, highlighting clinical relevance.
Purpose of the Study:
- To comprehensively review the current understanding of lncRNAs in papillary thyroid carcinoma (PTC).
- To explore the molecular mechanisms by which lncRNAs influence PTC.
- To assess the potential of lncRNAs as diagnostic and prognostic biomarkers for PTC.
Main Methods:
- Literature review of in vitro and in vivo studies on lncRNAs in PTC.
- Analysis of lncRNA expression patterns in PTC patient samples.
- Examination of lncRNA-mediated molecular pathways, including microRNA sponging and signaling pathway modulation.
Main Results:
- lncRNAs exhibit diverse roles in PTC, either promoting or suppressing tumor development.
- Key pathways targeted by lncRNAs in PTC include epithelial-mesenchymal transition, PI3K/Akt, and wnt signaling.
- lncRNAs function through mechanisms such as microRNA sponging.
Conclusions:
- lncRNAs represent a significant area of research in PTC, with substantial evidence supporting their roles in tumorigenesis.
- Further investigation into specific lncRNAs could yield novel diagnostic and prognostic biomarkers.
- Targeting lncRNAs offers potential for developing new molecularly targeted therapies for PTC.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
